Acacia research corp (ACTG)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss including noncontrolling interests in subsidiaries

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss including noncontrolling interests in subsidiaries

-

-

-

-

-

-

-203,781

-12,548

1,694

21,684

121,107

-30,366

-57,023

-54,799

-161,272

-195,521

-153,823

-157,478

-56,269

-41,751

-55,644

-66,662

-85,510

-88,161

-88,525

-58,842

-14,131

-5,112

14,749

59,289

45,271

62,284

57,742

21,645

0

0

0

Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:
Gain on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Change in fair value of investment, net (Note 5)

7,099

9,899

4,480

-15,465

-11,098

-59,103

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of investment (Note 5)

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

3,631

3,227

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of Series A redeemable convertible preferred stock embedded derivative

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of Series A warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of Series B warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

22,047

22,243

23,030

23,885

29,092

34,355

41,265

48,507

50,991

53,289

50,425

50,269

52,598

54,049

55,943

55,036

52,053

49,275

55,219

52,988

45,784

39,168

22,491

14,017

11,214

9,850

0

0

0

Non-cash stock compensation

1,415

1,075

264

-46

699

-317

-4,011

5,452

5,733

8,885

16,376

9,467

9,455

9,062

8,214

7,834

9,536

11,048

12,681

14,471

16,597

18,115

21,104

26,536

27,501

27,894

29,094

25,993

25,725

25,657

21,063

18,346

15,768

13,579

0

0

0

Change in value of trading securities

-4,841

2,241

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (Decrease) in Debt Securities, Trading

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of trading securities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from (Payments for) Trading Securities, Short-term

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-6,546

-5,522

5,293

0

0

0

0

Other

-

-

-

-

-

-436

-407

-89

-113

-374

-869

-1,093

-894

-477

-63

36

-28

-109

-131

-155

-40

-28

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Increase (Decrease) in Restricted Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-787

-18,130

-18,132

-20,645

-10,725

10,721

10,718

10,718

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-23,343

-32,373

-8,773

9,679

19,210

28,189

58,924

40,036

45,625

26,597

-39,900

23,420

-3,894

6,750

14,279

-59,889

-31,496

-13,332

-27,599

-15,289

-11,187

-13,827

2,894

15,408

-24,807

3,502

-13,679

-7,897

30,215

-6,928

-5,781

600

10,226

5,072

0

0

0

Prepaid expenses and other assets

463

220

1,008

1,232

-114

208

-826

-1,038

-1,010

-135

3,658

3,721

3,197

1,593

-2,379

-2,064

-1,187

-619

5,442

5,669

3,794

3,154

-12,885

-12,887

-6,899

-5,300

3,087

4,298

-552

-1,294

3,509

1,283

1,657

1,075

0

0

0

Accounts payable and accrued expenses

-3,142

109

237

1,708

2,241

963

1,311

-434

-2,708

-6,349

-15,006

-2,180

-2,849

-3,006

5,282

-18

1,970

2,570

895

-5,310

845

3,718

1,369

1,114

-4,950

2,740

-1,115

-4,178

382

2,255

10,200

13,511

8,740

-781

0

0

0

Royalties and contingent legal fees payable

-14,079

-20,510

-4,919

5,753

-23,788

19,359

-14,359

-6,390

35,131

-12,307

-5,185

-8,427

-15,540

-970

15,766

-2,327

-511

527

-8,534

-131

15,234

3,904

9,464

326

-32,841

-2,061

-13,165

883

22,641

-11,000

-15,572

-3,588

-7,641

10,748

0

0

0

Net cash used in operating activities

-2,561

-2,308

-52,370

-54,780

-31,051

20,877

-14,458

27,924

63,912

12,966

45,765

-9,059

21,975

34,061

11,115

34,289

16,991

-9,949

-7,551

-1,622

8,786

4,184

15,200

-22,252

-40,766

-3,509

29,554

59,302

72,476

104,603

86,681

98,876

73,090

60,590

0

0

0

Cash flows from investing activities:
Patent acquisition costs

10,200

4,420

0

0

0

-

-

-

-

-

-

-

-

1,225

1,000

1,837

3,643

19,504

37,732

39,317

58,620

42,746

39,163

40,897

22,038

25,061

123,716

144,085

180,170

178,260

76,835

53,310

16,100

14,680

0

0

0

Sale of investment at fair value (Note 5)

4,239

6,628

14,917

24,142

22,391

19,097

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of trading securities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Businesses, Net of Cash Acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150,000

150,000

150,000

150,000

0

0

0

0

Payments to Acquire Other Investments

-

-

-

-

-

-

-

-

38,514

31,514

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available-for-sale investments

-

-

-

-

-

-

89,326

166,871

307,545

448,388

424,945

344,368

236,785

62,633

62,633

49,677

9,927

23,296

57,129

99,900

109,098

109,963

123,014

138,010

196,702

279,693

330,302

337,590

354,963

402,500

305,007

248,379

153,189

8,427

0

0

0

Maturities and sales of trading securities

106,797

75,090

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities and sale of available-for-sale investments

-

-

-

-

-

-

-

-

369,108

467,790

397,800

321,577

145,914

43,232

32,352

54,732

63,536

82,115

130,352

138,219

152,062

182,115

217,579

234,302

234,740

239,370

308,889

298,583

355,498

322,236

169,016

117,487

20,025

60

0

0

0

Purchases of property and equipment

0

-

-

-

0

-

-

-

0

-

-

-

-

4

4

4

12

8

11

20

13

109

202

407

530

675

647

445

485

268

218

290

155

190

0

0

0

Net cash provided by (used in) investing activities

-13,990

-68,063

9,590

18,054

-41,323

-24,066

27,490

13,510

20,047

-16,114

-72,884

-78,530

-112,096

-40,630

-41,285

3,214

49,954

39,307

35,480

-1,018

-15,669

29,297

55,200

54,988

15,470

-66,059

-145,776

-183,537

-180,120

-408,792

-363,044

-334,492

-299,419

-23,237

0

0

0

Cash flows from financing activities:
Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

218,961

218,980

218,980

219,029

175,229

0

0

0

Repurchase of common stock

1,314

0

0

0

4,627

4,634

4,599

4,599

-18

0

92

92

107

82

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividend on Series A Redeemable Convertible Preferred Stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

25,434

25,357

25,275

25,159

25,039

25,014

24,997

24,888

18,633

0

0

0

-

-

-

-

-

-

-

-

Issuance of Series B warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Distributions to noncontrolling interests in operating subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,897

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

257

322

147

521

745

764

975

581

326

242

0

0

938

946

959

1,054

206

383

430

459

486

367

493

373

340

274

95

451

411

0

0

0

Contributions from noncontrolling interests in operating subsidiary, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,920

3,873

5,793

5,793

5,793

4,502

2,582

2,582

1,539

0

0

0

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,398

5,298

3,207

6,308

13,210

6,407

11,410

8,171

583

0

0

0

Net cash provided by financing activities

36,944

33,921

79

63

-4,630

-4,606

-4,551

-4,504

494

700

672

-475

-884

-1,114

-11,589

-16,815

-23,164

-28,601

-24,411

-24,316

-24,972

-25,700

-34,446

-35,605

-34,462

-25,551

-29,626

-23,722

-14,693

211,260

229,851

233,067

228,216

174,865

0

0

0

Increase (decrease) in cash and cash equivalents and restricted cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in cash and cash equivalents

-

-

-

-

-

-

8,481

36,930

84,453

-2,448

-26,447

-88,064

-91,005

-7,683

-41,759

20,688

43,781

757

3,518

-26,956

-31,855

7,781

35,954

-2,869

-59,758

-95,119

-145,848

-147,957

-122,337

-92,929

-46,512

-2,549

1,887

212,218

0

0

0

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,398

-21,122

-23,213

-20,112

-13,210

0

0

0

-

-

-

-

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,889

10,237

10,237

10,237

0

0

0

0

Payments to Acquire Notes Receivable

-

-

-

-

-

-

-

-

-

4,000

14,000

24,000

21,000

20,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent acquisition costs included in accrued expenses

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

2,350

16,700

-3,750

-1,508

19,250

4,000

0

0

0

-

-

-

-

-

-

-

-